Story by Lisa Masuku-Kurira
The Government has begun rolling out the long-acting HIV injectable drug Lenacapavir in Bulawayo, as government strengthen its fight against HIV and AIDS.
The rollout, which started on Monday following last week’s national launch, is targeting eligible patients from priority and high-risk groups. Health officials said beneficiaries are undergoing screening to determine suitability for the injection.
Authorities described the introduction of Lenacapavir as a major milestone in HIV prevention, citing its potential to reduce pill burden while offering a discreet and long-acting alternative to daily oral medication.
Acting Bulawayo Provincial Medical Director, Dr Shirley Takaza, said the development marked significant progress in the national response.
“Today we are launching the rollout of the HIV injectable drug. This is a huge milestone; it marks a significant step towards enhancing the fight against HIV,” she said.
Members of priority populations welcomed the initiative, saying it would strengthen protection, particularly for those whose work makes daily adherence to medication challenging.
“As sex workers, we are very happy. Sometimes you go out in the field and get stuck for days without enough medication. We are very grateful for this life-changing injection. We believe it will really go a long way in enhancing our protection,” said one beneficiary.
Sexual health and HIV/AIDS research expert Dr Byron Chingombe said the injection represents a breakthrough in treatment and prevention.
“This groundbreaking injection reduces pill burden. It is also discreet and self-empowering,” he said.
Zimbabwe has recorded notable progress in the fight against HIV and AIDS, with new infections and HIV-related deaths continuing to decline, according to health authorities.
